| Announce Date | 02/12/2026 |
| EPS Normalized Actual | $1.17 (Miss by $-0.16) |
| EPS GAAP Actual | $1.17 (Miss by $-0.16) |
| Revenue Actual | $1.83375B |
| Revenue Surprise | Beat by $1833.75M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.49357 |
| EPS GAAP Estimate | $1.49357 |
| Revenue Estimate | $1.8838485B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 7.11 | 16.09 | 6.8724 | 7.31797 | 1 |
| Dec 2027 | 0 | INF | 0 | 0 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.86 | -0.45381 | 1.83375B | 7.66% | 11.09M |
| FQ2 2025 (Jun 2025) | 0.64 | 0.64 | 1.7378B | 0.28% | 1737.8M |
| FQ1 2025 (Mar 2025) | 0.69 | 0.69 | 1.7004B | -9.56% | 1700.4M |
| FQ4 2024 (Dec 2024) | 2.37 | 2.37 | 1.8388B | -0.09% | 1838.8M |
| FQ3 2024 (Sep 2024) | 0.26 | 0.26 | 1.69332B | 1.26% | 1693.32M |
| FQ2 2024 (Jun 2024) | 1.01 | 1.01 | 1.73293B | 100% | 1732.93M |
| FQ1 2024 (Mar 2024) | 1.95 | 1.95 | 1.86291B | 100% | 1862.91M |
| FQ3 2023 (Sep 2023) | -1.03 | -1.03 | 1.67194B | 100% | 1671.94M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.49357
Consensus Revenue Estimates
1.8838485B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.54489 | -- | 1.47479 | 1.62133 | 7 |
| FQ3 2027 (Sep 2027) | 1.37 | -- | 1.34666 | 1.40413 | 2 |
| FQ2 2027 (Jun 2027) | 1.56 | -- | 1.53342 | 1.59886 | 2 |
| FQ1 2027 (Mar 2027) | 1.56 | -- | 1.53342 | 1.59886 | 2 |
| FQ4 2026 (Oct 2026) | 1.46579 | -- | 1.41323 | 1.55125 | 3 |
| FQ3 2026 (Jul 2026) | 1.51042 | 43.06 | 1.45626 | 1.59848 | 3 |
| FQ2 2026 (Jun 2026) | 1.51042 | 57.63 | 1.44789 | 1.57302 | 5 |
| FQ1 2026 (Mar 2026) | 1.49357 | 53.8 | 1.43174 | 1.55547 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.92B | -- | 1.85B | 1.99B | 5 |
| FQ3 2027 (Sep 2027) | 1.81B | -- | 1.78B | 1.84B | 3 |
| FQ2 2027 (Jun 2027) | 1.8B | -- | 1.78B | 1.84B | 3 |
| FQ1 2027 (Mar 2027) | 1.77B | -- | 1.75B | 1.81B | 3 |
| FQ4 2026 (Oct 2026) | 1.93B | -- | 1.88B | 2.02B | 4 |
| FQ3 2026 (Jul 2026) | 1.88B | 2.65 | 1.83B | 1.97B | 4 |
| FQ2 2026 (Jun 2026) | 1.88B | 7.75 | 1.82B | 1.94B | 6 |
| FQ1 2026 (Mar 2026) | 1.88B | 9.74 | 1.82B | 1.94B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.31381 | 0.86 | -0.45381 | -52.77% |
| FQ2 2025 (Jun 2025) | 0.64 | 0.64 | 100% | |
| FQ1 2025 (Mar 2025) | 0.69 | 0.69 | 100% | |
| FQ4 2024 (Dec 2024) | 2.37 | 2.37 | 100% | |
| FQ3 2024 (Sep 2024) | 0.26 | 0.26 | 100% | |
| FQ2 2024 (Jun 2024) | 1.01 | 1.01 | 100% | |
| FQ1 2024 (Mar 2024) | 1.95 | 1.95 | 100% | |
| FQ3 2023 (Sep 2023) | -1.03 | -1.03 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.82B | $1.83B | $11.09M | 0.61% |
| FQ2 2025 (Jun 2025) | $0B | $1.74B | $1737.8M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.7B | $1700.4M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.84B | $1838.8M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.69B | $1693.32M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.73B | $1732.93M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.86B | $1862.91M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $1.67B | $1671.94M | 100% |